Uncategorized

$TGODF $TGOD.V Continues to Build Top-Level Management Team

TORONTO, Oct. 18, 2018 – The Green Organic Dutchman Holdings Ltd. (the Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce two strategic appointments within its leadership team, with Emily Demeo joining as Marketing Brand Director and Terry Reid joining as Director, Legal and Compliance.

Ms. Demeo most recently led the innovation strategy for Molson Coors Canada, including the long-range pipeline for new and existing brands. She was responsible for Molson’s growth plan in Beyond Beer and Non-Alcoholic Segments and established a proven track record for driving innovation within a regulated industry. Prior to Molson, Emily held positions of increasing responsibility at L’Oreal, most recently as Senior Product Manager for Garnier Fructis. She was responsible for developing all aspects of the marketing mix and identified growth opportunities for a globally-recognized marketing organization.

Emily will drive the global TGOD brand by leading the long-term innovation pipeline. This will include development of the edibles strategy, where her beverage industry experience will help drive strategic brand development. As well, she will direct the branded accessories strategy, with the opportunity to build value-added products for the Company’s consumers around the world.

“We are pleased to add a Marketing executive of Emily’s calibre to the TGOD team,” said Andrew Pollock, Vice President of Marketing. “We have received tremendous feedback from consumers about our organic-certified platform, and now Emily will help drive that strategy across a number of verticals. She has a winning track record and a keen understanding of the organic consumer.”

Mr. Reid joins TGOD following a successful career at Teva Pharmaceuticals, where he was a key member of both the legal and compliance teams, most recently as Head of Compliance for Canada. In this role, Mr. Reid led the development and implementation of compliance policies and risk management plans to identify and mitigate compliance risks, working extensively with the local business and global counterparts to ensure operational compliance across a global organization. Prior to his role at Teva, Mr. Reid had a successful commercial litigation practice at a reputable Toronto law firm.

“We are thrilled to have Terry join the TGOD Legal team,” said Anna Stewart, General Counsel for TGOD. “Terry’s deep expertise in regulated industry compliance will be essential as TGOD rapidly expands its business across different and evolving regulatory environments and various product offerings including edibles and beverages.”

ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD

The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg of cultivation facilities in Ontario and Quebec and Jamaica.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about the future legalization of recreational cannabis and cannabis-infused products in Canada, statements about future research, development and innovation by the Company, statements about the offering of any particular products by the Company in any particular territory and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Thursday, October 18th, 2018 Uncategorized Comments Off

$VVCIF Harvest Medicine Continues National Expansion with Acquisition of Trauma Healing Centres

NAPANEE, Ontario, Oct. 17, 2018  — VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Harvest Medicine Inc. (“Harvest Medicine” or “HMED”), has completed the acquisition of Trauma Healing Centres (“THC”) from Organigram Holdings Inc..

THC is a multi-disciplinary clinic network that has been providing medical cannabis care and education to thousands of patients in Nova Scotia, New Brunswick and Ontario since 2014. THC specializes in patient assessment and medical cannabis prescribing and also offers patients individualized, multi-disciplinary wellness plans.

Both THC and Harvest Medicine share a deeply ingrained patient-centric approach to care. The transition of THC to Harvest Medicine offers THC the opportunity to flourish under an experienced medical management team, wholly committed to the day-to-day operation of exceptional medical cannabis clinics.

“We are pleased to see two excellent organizations join forces to offer Canadian medical cannabis patients access to outstanding care,” says Greg Engel, CEO, Organigram. “We are proud of our relationship with THC and look forward to seeing the outstanding team at Harvest take the delivery of care to the next level.”

“THC’s reputation with the veteran community as a trusted resource and partner, and its commitment to providing exceptional patient care make it an excellent fit with Harvest Medicine,” stated Shekhar Parmar, President of HMED. “This acquisition accelerates our national expansion plans and we look forward to building on THC’s success in these markets and continuing to ensure patients have improved access to our best-in-class services.”

The transaction will see HMED acquire 100% of the issued and outstanding shares of THC from Organigram. The total purchase price for the shares will be $1,200,000, to be satisfied by the issuance of common shares in the capital of VIVO at a price per share equal to the ten trading day volume weighted average price immediately prior to the closing of the transaction.

With this acquisition HMED will add locations in Nova Scotia, New Brunswick, and Ontario to its existing network of medical cannabis clinics in Edmonton and Calgary.  The transaction will also add another 4,500 patients to HMED’s existing patient base, bringing the total number of active HMED patients to above 22,000.

“Our physical locations and our soon to be released telemedicine platform, HMED Connect, complement each other to ensure enhanced seamless service, flexibility and greater scalability for HMED and its patients” said Mr. Parmar. “Our vision is to transform the medical cannabis experience for patients and physicians and be recognized as the trusted leader in medical cannabis care across the country.”

About Trauma Healing Centers

Trauma Healing Centers is a resource center for anyone suffering from post-traumatic stress disorder (PTSD), trauma, chronic pain, cancer treatment or other disabling illness including veterans, RCMP, first responders and civilians. Our team of dedicated professionals will work with patients on an individual basis to provide a wellness plan to enhance their quality of life.

About Harvest Medicine

Harvest Medicine (“HMED”, www.hmed.ca) is an education focused, patient-centric, network of specialty medical cannabis clinics where patients receive best in class education, care, advice and follow-up support as they approach cannabinoid-based medicine.

Growing to over 15,000 active patients in under 18 months, HMED is one of Canada’s most successful and fastest growing cannabis clinic networks. With the imminent launch of HMED Connect, a free telemedicine app and service, and the acquisition of Trauma Healing Centres, HMED is focused on aggressively expanding its effective and highly scalable model across the country.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. In anticipation of the legal adult use recreational cannabis in Canada, Organigram has developed a portfolio of brands including The Edison Cannabis Company, Ankr Organics and Trailer Park Buds. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

About VIVO Cannabis™

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licences from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical™, FIRESIDE™, Canna Farms™ and Lumina™. In August 2018, VIVO acquired Canna Farms Limited, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a soon to be released free telemedicine app. VIVO has a healthy balance sheet with approximately $100 million in cash and is well-positioned to accelerate the growth of our business, in Canada and internationally.

Disclaimer for Forward-Looking Information

This news release contains forward-looking statements, including statements regarding the financial performance, reputation and impact of acquiring Trauma Healing Centres, as well as the successful launch of HMED Connect, the potential benefits to patients of using these services, and the potential benefit to HMED of acquiring these additional clinics. The forward-looking statements in this release are based on certain assumptions and involve known and unknown risks and uncertainties and other factors that could cause actual events to differ materially from current assumptions and expectations, including that the acquired locations will continue to be viable business operations, patients may not find the services helpful and regulations around medical cannabis education and use may change. These forward-looking statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, including that there may be regulatory impediments to the success of medical cannabis clinics and HMED Connect; and that there may be operational and technical challenges integrating Trauma Health Centres processes with Harvest Medicine and HMED Connect. A more complete discussion of the risks and uncertainties facing the Company appears in the Company’s Annual Information Form for the year ended December 31, 2017 and other continuous disclosure filings, which are available on SEDAR at www.sedar.com. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason, other than as required by applicable securities laws.

More Information

Barry Fishman, CEO:                  barry.fishman@vivocannabis.com 
Michael Bumby, CFO:                 michael.bumby@vivocannabis.com 
Shekhar Parmar, CEO, HMED   sp@hmed.ca 

VIVO Website:                            vivocannabis.com
Wednesday, October 17th, 2018 Uncategorized Comments Off

$SNNVF to Acquire Northern California Licensed Cultivation and Genetics Facility

Sunniva Inc. (“Sunniva” or the “Company“) (CSE:SNN) (OTCQX:SNNVF), a North American provider of cannabis products and services, is pleased to announce that the Company has signed a non-arms length binding letter of intent dated October 16, 2018 with the Oakland Vision Project (“Vision”) to acquire all the issued and outstanding equity interests of the companies that comprise Vision (the “LOI”).  Vision is co-owned by Vinayak Shastry, Sunniva’s President of US Operations.  Vision operates a licensed cultivation facility located in Irvine, California (the “Vision Facility”).   Completion of the acquisition remains subject to a number of conditions including, among other things: the negotiation and execution of a definitive agreement between Sunniva and Vision, completion of due diligence and receipt of regulatory approvals, including approval of the Canadian Securities Exchange (“CSE”).

The Vision Facility is lead by a seasoned group of cultivation professionals who have experience in both small and large-scale operations. The cultivation team is currently producing some of the highest quality pesticide free cannabis flower in California. The acquisition will provide Sunniva with:

  • A proven cannabis cultivation team to manage Sunniva’s production operations in California
  • Proof of concept of Sunniva’s strategy focussed on full vertical integration across the entire value chain, from seed to sale
  • Current production capacity of ~1,600 lbs per year with development plans to scale production to ~8,000 lbs per year in 2019, with an estimated capital investment of $1.5 million and estimated production costs below $1.00 per gram
  • Clean clones for onboarding into the Sunniva California Campus
  • Library of more than 20 proven genetic strains with on-site genetics lab for the development of future strains
  • Premium flower and trim to launch high end Sunniva branded product lines

“This acquisition will deliver full vertical integration in California that strategically enhances the value of the Sunniva brand.  Production from this facility will allow Sunniva to launch its first premium-quality craft flower brand with the assurance of large-scale production from this facility and the large-scale 325,000 sqft purpose-built, high technology Sunniva California Campus greenhouse. The key to brand success in California will be the ability to produce high-quality pesticide-free products at a large-scale.  This acquisition and our state-of-the-art cultivation and extraction facility positions us as a market leader in California,” commented Leith Pedersen, President of Sunniva.

“Sunniva has recently assembled a preeminent in-house marketing team that is developing a house of brands that will include high end extracts, flower, pre-rolls, vaporizer and vape cartridges along with a future beverage line. We are excited to immediately show proof of concept with this strategic acquisition demonstrating vertical integration from seed to sale and we anticipate the initial Sunniva house of brands to be launched commencing January 2019.”

Total transaction consideration will be USD $1 million through the issue of common shares of Sunniva Inc. (“Shares”) upon closing and up to an additional USD $2 million through the issue of Shares based on the achievement of certain operational milestones by the end of 2019.  The Company is not assuming any long-term debt of Vision as part of the transaction and there are no finder’s fees payable.  The number of Shares issued will be based on a price per Share of $5.24, which is the volume weighted average trading price of the Shares on the CSE for the five (5) trading days prior to execution of the LOI.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California.  Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through our strategically positioned cultivation and extraction facilities, we are launching Sunniva branded products in various product categories including flower, pre-rolls, beverages, vape cartridges, extracts as well as aggressively pursuing upstream vertical opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

About the Oakland Vision Project.

The Oakland Vision Project (Oakland Vision Project Leasing, LLC, Oakland Vision Project, Inc. and Vision Alchemy, LLC) have been in business since 2015 producing high-grade cannabis flower in California. Lead by a well-established cultivation team which has developed proprietary IP and standard operating cultivation procedures in order to maximize production yields while ensuring costs below $1.00 per gram. The Vision team have extensive knowledge, understanding and expertise operating a vertically integrated cannabis facility in California.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”), including, but not limited to, statements with respect to the conditions of completing the acquisition, including negotiating and executing the definitive agreement, regulatory approvals, and future production estimates, timing and costs from the Vision Facility.  Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Company Contact:
Dr. Anthony Holler
Chairman and Chief Executive Officer

Investor Contact:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com

Media Contact:
Katelyn Tumino
KCSA Strategic Communications
Phone: (212) 896-1252
Email: ktumino@kcsa.com

Wednesday, October 17th, 2018 Uncategorized Comments Off

$TGODF North American Cannabis Industry Growth Set to Explode as a New Era Begins

Palm Beach, FL – (October 17, 2018) — North American demand for legal marijuana is expected to jump dramatically as Canada will officially commenced its legalization of recreational marijuana today. According to the Cannabis Business Plan, recreational cannabis could experience annual revenues north of $8 billion by 2020 in Canada alone. This is forcing industry leaders to reinvest profits into the expansion of cultivation efforts as the consumer base grows and new markets emerge. Additionally, the momentum from other countries around the world, including the United States, is driving the industry forward as well. The upcoming mid-term election will feature cannabis as a prime topic for candidates and voters alike. The billion dollar industry has already exploded, but the growth will only continue to be steady as North America approaches full-recreational legalization.  Active companies in the industry making moves to ready that include:  Choom™ Holdings Inc. (CSE:CHOO) (OTC:CHOOF), Aphria Inc. (TSX:APH.TO) (OTCQB:APHQF), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX:TGODF), Cronos Group Inc. (NASDAQ:CRON)(TSX:CRON), TerrAscend Corp. (CSE:TER.CN) (OTCPK:TRSSF).

Choom™ Holdings Inc.  (CSE: CHOO) (OTCQB: CHOOF) BREAKING NEWS:  Choom™, a n emerging adult use cannabis company is pleased to report on this historic date – the legalization of adult use cannabis in Canada and the end of prohibition – that its wholly-owned subsidiary, Specialty Medijuana Products Inc., has received a cultivation license from Health Canada.

October 17, 2018 will go down in Canadian history as the day cannabis was legalized for adult use from coast to coast, ending almost a century of prohibition. Choom is poised to become a major retail player in the adult use cannabis space, with stores scheduled to open across the country.

Choom has secured the rights to 52 retail opportunities across Western Canada and its rapidly expanding Alberta presence now stands at 29 in highly strategic and secure locations, with 14 Development permits and 11 building permits received from the various municipalities. With recently amended regulations in Ontario, Choom has deployed its real estate team throughout the province of Ontario to secure a significant cannabis retail footprint in Canada’s largest adult use market.

Choom™ is executing an aggressive expansion plan to create a significant retail storefront brand in the Canadian adult use market and is committed to developing and acquiring retail stores as a top priority. In all cases, the retail opportunities are subject to all necessary governmental and municipal approvals being granted. This number is expected to grow over the coming months as the Company is currently negotiating additional leases with the intention of submitting applications for retail licenses.

Chris Bogart, CEO of Choom Holdings Inc, comments: “Now that legalization is finally here, we are continuing to aggressively roll out our retail strategy. We see a massive opportunity in the retail market, and our goal is to build Choom into an iconic Canadian retail storefront brand. This officially marks opening day in the adult use cannabis market in Canada, and we look forward to the day when Choom is synonymous with good times with good friends from coast to coast.”   Read this and more news for Choom™ at:     http://www.financialnewsmedia.com/news-choo/

Additional industry related developments from around the markets:

Aphria Inc. (TSX:APH.TO) (OTCQB:APHQF) earlier this week announced that it has completed its first shipment of cannabis oil to its Argentina -based subsidiary ABP, S.A. (“ABP” or the “Argentinean Company”), a pharmaceutical import and distribution company. In accordance with a previously announced supply agreement, the Company delivered 1,500 bottles of Aphria’s renowned Rideau CBD oil, which were provided to Hospital de Pediatria Garrahan (“Hospital Garrahan” or the “Hospital”), a leading pediatric hospital located in Buenos Aires , for use in a clinical study focused on treating refractory epilepsy in children. Aphria acquired ABP last month when the Company closed its acquisition of LATAM Holdings Inc. (“LATAM Holdings”), expanding the Company’s global footprint to include a leading presence in Latin America and the Caribbean . ” Argentina will play a foundational role as Aphria cements its leadership in medical cannabis throughout the region,” said Vic Neufeld , Chief Executive Officer of Aphria. “Aphria and ABP, in close partnership with the Argentinean government, continue to advance opportunities for medical cannabis in the country, including the potential for in-country cultivation. We are also proud to support the critical and necessary research being undertaken by Hospital Garrahan on the treatment of refractory epilepsy in children with our Rideau CBD oil.”

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX:TGODF) on Tuesday announced it has received its medical sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) for its Ancaster, Ontario facility. “As we prepare for our Founders Club product launch in January 2019 , this is a critical step in our path to becoming the global leading organic cannabis brand,” said Brian Athaide , CEO of TGOD. “We have been perfecting our organic grow methodology in Ancaster and are prepared for the Q1 launch to medical patients across Canada followed by the launch in adult use markets in Q2.” “We have been working aggressively on both productive capacity and global distribution,” said John Wren , VP of Operations at TGOD. “In addition to Ancaster , we are currently growing in Valleyfield, Quebec at our breeding facility, Jamaica with our partner Epican and Poland with HemPoland. We are on track to progressively ramp up our production throughout 2019, targeting 195,000 kgs of run-rate capacity by the end of the year. TGOD is securing significant distribution networks in Canada , Europe , Jamaica , and Latin America while scaling operations for medical and adult use markets around the world,” continued Mr. Wren.

Cronos Group Inc. (NASDAQ:CRON)(TSX:CRON) earlier this week announced that it has entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion – Israel Institute of Technology (“Technion”) to explore the use of cannabinoids and their role in regulating skin health and skin disorders. The preclinical studies will be conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and skin repair. Research will be led by Technion faculty members Dr. David “Dedi” Meiri, Head, Laboratory of Cancer Biology and Cannabinoid Research and Dr. Yaron Fuchs, Head, Laboratory of Cancer Biology and Cannabinoid Research, two of the world’s leading researchers in cannabis and skin stem cell research, respectively. Dr. Meiri heads the Laboratory of Cannabis and Cancer Research with vast experience in cannabis and endocannabinoid research. Dr. Fuchs heads the Laboratory of Stem Cell Biology and Regenerative Medicine with years of experience in the biology of the skin and its pathologies. Development and implementation of the research will be conducted at Technion’s Laboratory of Cancer Biology and Cannabis Research and the Lorry I. Lokey Interdisciplinary Center of Life Sciences and Engineering in Haifa, Israel.

TerrAscend Corp. (CSE:TER.CN) (OTCPK:TRSSF) recently announced that its subsidiary TerrAscend Canada Inc. has entered into a multi-year cultivation agreement with PharmHouse Inc. (“PharmHouse”), a joint venture between Canopy Rivers Inc. (RIV.V) (“Canopy Rivers”) and the principals and operators of a leading North American greenhouse produce company. Under the terms of the agreement, PharmHouse will grow and supply cannabis to TerrAscend Canada from an existing 1.3 million square foot greenhouse (“Facility”), located in Leamington , Ontario. Once fully licensed, the production of flower, trim and clones from 20% of the dedicated flowering space at the Facility will be made available to TerrAscend Canada. TerrAscend Canada may provide proprietary genetic strains to PharmHouse and help oversee production in conjunction with their operators and quality assurance professionals. Cultivation is anticipated to commence in 2019, subject to receipt by PharmHouse of all applicable regulatory licenses and approvals.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press release issued above by Choom™ Holdings Inc. by a non affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact email: editor@financialnewsmedia.com – +1(561)325-8757

Wednesday, October 17th, 2018 Uncategorized Comments Off

$YGYI Details Expanded Distribution of Café La Rica Brand across Southeastern US

Leading omni-direct lifestyle company Youngevity International, Inc. (NASDAQ: YGYI) this morning announced the planned expansion of its Café La Rica brand into over 500 retail stores and 125 cafeterias. Per the update, the expanded distribution agreement now includes all Winn Dixie and Bi-Lo locations, in addition to 125 Winn Dixie Cafeterias, broadening Café La Rica’s retail presence into Georgia, Alabama, Louisiana, Mississippi, North Carolina and South Carolina. “We are very proud to have our Café La Rica Espresso expand so significantly,” Ernesto Aguila, president of CLR and founder of the Café La Rica Brand, stated in the news release. “We are quite enthusiastic to see our brand expanding outside of Florida into six additional states.”

To view the full press release, visit: http://nnw.fm/HW2oV

About Youngevity International, Inc.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers proven products from the six top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The company was formed during the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Tuesday, October 16th, 2018 Uncategorized Comments Off

$TGODF Obtains Medical Sales License for Ancaster Facility

TORONTO, Oct. 16, 2018 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce it has received its medical sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (the “ACMPR“) for its Ancaster, Ontario facility.

“As we prepare for our Founders Club product launch in January 2019, this is a critical step in our path to becoming the global leading organic cannabis brand,” said Brian Athaide, CEO of TGOD. “We have been perfecting our organic grow methodology in Ancaster and are prepared for the Q1 launch to medical patients across Canada followed by the launch in adult use markets in Q2.”

“We have been working aggressively on both productive capacity and global distribution,” said John Wren, VP of Operations at TGOD. “In addition to Ancaster, we are currently growing in Valleyfield, Quebec at our breeding facility, Jamaica with our partner Epican and Poland with HemPoland. We are on track to progressively ramp up our production throughout 2019, targeting 195,000 kgs of run-rate capacity by the end of the year. TGOD is securing significant distribution networks in Canada, Europe, Jamaica, and Latin America while scaling operations for medical and adult use markets around the world,” continued Mr. Wren.

On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.

ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.

The Green Organic Dutchman Holdings Ltd. is a premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe and Latin America and the soon to be legal Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg and is building 1,382,000 sq. ft. of cultivation facilities across Ontario, Quebec and Jamaica.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about the future legalization of recreational cannabis and cannabis-infused products in Canada, statements about future research, development and innovation by the Company, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

Tuesday, October 16th, 2018 Uncategorized Comments Off

$NETE Stands to Benefit in Booming Russian E-Commerce

  • Russian ecommerce still 80 percent reliant on cash
  • Net Element’s “PayOnline” payments platform to cash in on trend toward non-cash
  • Strategic partnerships pave entry to Russian mobile and online payments market

In Russia, cash on delivery is not just a way to pay for takeout; it’s how over 80 percent of online purchases are remunerated, according to Ecommerce News Europe (http://nnw.fm/XeJw8). However, that is changing fast. In 2017, “financial cards and payments performed positively in Russia”, says Euromonitor International (http://nnw.fm/G9M4u). Russian consumers are changing their purchasing habits, it seems, as financial literacy and cashless payment solutions, like those offered by Net Element, Inc. (NASDAQ: NETE), come to market. A recent report from Zacks notes, “Net Element is a growth company in the payments industry that should benefit from the adoption of mobile and online payments in the U.S., Russia and Eastern Europe.” In fact, Net Element is the only U.S. company listed on the Nasdaq that stands to benefit from the Russian electronic payments expansion.

Russian consumers are a cautious lot, paying only for goods when they are received. Merchants display an equal degree of circumspection; they typically prefer cash-on-delivery (COD). COD in America was widely employed during the heyday of mail order commerce but has since been superseded by debit cards, credit cards and web-based payment systems. In other countries, COD is still an option. In the Middle East, around 60 percent of online transactions are completed by COD, prompting one commentator to lament (http://nnw.fm/jw5zV), “Cash on delivery is the biggest challenge for e-commerce players in the region. There are high return rates, a big lag time between order and payment and the need for delivery people to carry cash is a major risk.” The same challenges beset ecommerce in Russia. However, a payment platform like the one developed by Net Element is catalyzing consumer acceptance of non-cash payment.

The potential of this emerging market is not to be underestimated. Citing a recent report from Morgan Stanley, this column discloses that in the five-year period from 2018-2023, the Russian e-commerce market will grow by more than two-and-a-half times – to 3.491 trillion rubles ($53.15 billion) – from 1.292 trillion rubles ($19.67 billion) in 2018. In 2017, “the Association of E-commerce Companies (ACIT) estimated the volume at 1.04 trillion rubles ($15.83 billion).”

Net Element is on it. In 2017, the company’s PayOnline subsidiary launched Apple Pay support in Russia (http://nnw.fm/w9VIE). The global number of Apple Pay users is growing at a rate of over one million per week, while transaction volumes are up 500 percent over the last year. Since launching in Russia on October 4, 2016, the number of Apple Pay users in the country has increased to an estimated 200,000 and continues to grow. As a fully integrated electronic commerce platform, PayOnline is at the forefront of the payments industry in the region and poised for expansion into Russia. It is well positioned to capitalize on this developing trend by enabling and supporting mobile and e-commerce merchants to accept Apple Pay.

PayOnline is also collaborating with Bank Sputnik to offer a comprehensive multi-channel payment facilitator solution for SMB merchants in the Russian Federation (http://nnw.fm/3gwuT). This unique solution offers a set of tools not available from any other transaction processing company in the region and expands PayOnline’s offerings beyond electronic commerce. Under the exclusive partnership, Bank Sputnik will offer a fully compliant legal framework and bank sponsorship to enable PayOnline to process transactions as a payment facilitator. By provisioning a single, master merchant ID, PayOnline ensures that merchants and their clients benefit from an automated, real-time and seamless onboarding experience. The API-driven platform simplifies merchant account enrollment. A sub-merchant can be enrolled, approved, boarded and processing payments in a few minutes.

Net Element offers a broad range of payment acceptance and processing services that enable merchants of all sizes to accept and process over 100 different payment options in more than 120 currencies, including credit, debit, prepaid and alternative payments. The company also provides merchants with value-added services and technologies, including integrated payment technologies, POS solutions, security solutions, fraud management, information solutions and analytical tools.

For more information, visit the company’s website at www.NetElement.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Tuesday, October 16th, 2018 Uncategorized Comments Off

$TGODF 420 with CNW – Poll Shows 62 Percent of Americans Favor Marijuana Decriminalization

A recent poll conducted by Pew Research Center shows that 62 percent of all Americans want cannabis to be legalized. The findings are in line with previous polls which have been showing an increase in the number of citizens who favor marijuana legalization.

A total of 1,754 adults were interviewed by phone and their responses showed the highest support for decriminalization since Pew Research Center started conducting yearly polls about the sentiments of citizens regarding marijuana.

This increased support may have been fueled by the legalization of pot in several states as well as D.C.

However, the rate at which support for cannabis legalization is growing seems to have hit a plateau since the recent polls show modest increases in support. Last year, the figure stood at 61 percent, meaning that support has grown since then by one percentage point in 2018.

Political affiliation seems to play a role in people’s attitudes towards marijuana legalization. The poll discovered that Democrats are more likely to favor decriminalization when compared to Republicans. Roughly 69 percent of the Democrats polled in the study supported legalization, while only 45 percent of the Republicans expressed a similar sentiment.

It isn’t therefore surprising that Trump’s Republican government set up a secret committee to collect negative information about marijuana in order to portray it has a danger to the nation.

However, the tide is also turning among Republicans as well. For example, Republicans in Texas expressed their support for the removal of custodial sentences for adults found in possession of small amounts of marijuana. The nearly five in 10 Republicans who supported marijuana legalization in this study are an increase from the 39 percent who were in favor of legalization in 2015.

The study also revealed that age may be a factor when matters of marijuana legalization arise. For example, nearly three-quarters of all Millennials polled supported legalization while just over half of the Baby Boomers supported decriminalization. Not surprisingly, those aged 76-93 had the least support for marijuana legalization with only 39 percent saying it was time to get cannabis off the list of contraband substances. The older one is, the less likely that person may be to support marijuana legalization.

If these statistics are anything to go by, the federal government is likely to have its hand forced once most states make it legal to use cannabis either for medical or recreational purposes. The process is already underway in several states, so 2019 is likely to see a higher number of states where marijuana is legal. The Flowr Corporation (TSX.V: FLWR) and The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) must be waiting for that day when the entire U.S. market will be opened to them.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Monday, October 15th, 2018 Uncategorized Comments Off

$DPW Investment in Tribeca Hotel Secures $85 Million Construction Loan Commitment

Newport Beach, CA, Oct. 15, 2018  — DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company (“DPW”), announced that a group which includes DPW as an investor secured an $85 million construction loan commitment from a New York City-based multinational investment bank for the construction of a five-star ultra-luxury hotel in Tribeca (the “Hotel”). and led by two New York real estate development companies, Mactaggart Family & Partners LP and Caspi Development, As announced on May 25, 2018, DPW Holdings acquired a minority position in the investment.

“DPW seeks assets with unique attributes and significant promise,” said Milton “Todd” Ault III, DPW’s CEO and Chairman. “With strong luxury hospitality fundamentals and specific location advantages the Hotel is positioned to capitalize on the exploding business and residential growth of Lower Manhattan. This loan commitment from a prestigious bank validates our opportunity and keeps the Hotel on track to be completed in the summer of 2020. The anchor of DPW’s hospitality portfolio, the Hotel is expected to deliver long-term predictable cash-flow.”

The Tribeca Hotel 
The 94,000 square foot hotel, located one block east of the Hudson River in the heart of the Tribeca North Historic District, will feature 96 opulently appointed rooms and suites, a lavish full-service spa and six first-class food and beverage venues, all exclusively designed by renowned designers Martin Brudnizki Design Studio and Stephen B. Jacobs Group. A 106-year, premier hospitality group among the largest operators of 5-star luxury hotels and casinos in Europe will share its flagship hotel’s name, sophistication and exclusive service. The group is expected to be revealed as part of a branding effort that will commence in the spring of 2019. A record-number Michelin star restaurateur is also contracted to oversee dining in the Hotel, including the New York manifestation of an iconic European institution in operation since the 1800s. AECOM Tishman Construction Corp. broke ground in December 2017 and expects to open the 96-room hotel during the fall of 2020, with the opening of the restaurants anticipated to be immediately thereafter. For more information regarding the hotel project, please use this link where a live video feed is also featured streaming during the day, https://DPWHoldings.com/456luxhotelnyc/.

DPW Investment 
To maximize long-term predictable cash flow, DPW intends to invest pari passu with top-tier New York City real estate investors. Based on a projected average daily rate (ADR) of $983 upon stabilization in 2021 (as compared to the competitive set’s May 2016 ADR of $1,060), the Hotel is expected to produce a stable, unlevered yield on cost of 10%. A refinancing, three years after opening, is projected to return 50% of the invested equity and should generate cash-on-cash returns of 18% thereafter.

Partners
London-based Mactaggart Family & Partners, LP has been operating in New York City since 1985. Its experience spans over 35 years of high-end office and residential development including 589 Fifth Avenue, 590 Fifth Avenue, 183 Madison Avenue, and 576 Fifth Avenue.

Family-run Caspi Development represents decades of real estate pedigree, which along with a comprehensive hands-on approach, has led to an unparalleled reputation for perfection in design, construction and project completion. With a track record of both metropolitan and suburban achievements, Caspi thrives in the competitive Westchester and New York City landscapes. Bringing three generations of experience to the table, Caspi taps into its knowledgeable site selection and financial entrepreneurship to succeed in a variety of markets.

About DPW Holdings, Inc.
DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly owned subsidiaries and strategic investments, the company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, crypto-mining, and textiles. In addition, the company owns a select portfolio of commercial hospitality properties and extends credit to select entrepreneurial businesses through a licensed lending subsidiary. DPW Holdings, Inc.’s headquarters is located at 201 Shipyard Way, Suite E, Newport Beach, CA 92663; www.DPWHoldings.com

Forward-Looking Statements
The foregoing release contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at www.DPWHoldings.com.

 

Contacts: 
Kirsten Chapman, LHA Investor Relations, 415.433.3777, dpwholdings@lhai.com
Monday, October 15th, 2018 Uncategorized Comments Off

$RIV.V Significant Contract Manufacturing Agreement

TORONTO, Oct. 15, 2018 – Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV:RIV) is pleased to announce PharmHouse Inc. (“PharmHouse”), has entered into an offtake agreement (the “Agreement”) to supply TerrAscend Canada Inc. (“TerrAscend Canada”), a wholly-owned subsidiary of TerrAscend Corp. (“TerrAscend”) (CSE:TER),  with cannabis products from 20% of the flowering space at its 1.3 million square foot greenhouse facility until December 31, 2021.

Both PharmHouse and TerrAscend are substantial pillars in the Canopy Rivers’ investment portfolio, and this Agreement represents a de-risking milestone for each company.  Leveraging the anticipated throughput and low cost of production from the PharmHouse facility positions TerrAscend Canada with a sizeable source of dried flower and trim for packaging, processing, and distribution throughout the TerrAscend logistics platform without the need for considerable capital expenditures. For PharmHouse, the Agreement provides increased sales visibility and financial de-risking for a significant portion of the expected production from its flagship facility.

“We are seeing promising synergies develop within the Canopy Rivers portfolio,” said Bruce Linton, Chairman and Acting CEO of Canopy Rivers, and co-CEO of Canopy Growth Corporation. “We set out to create an ecosystem of complementary cannabis companies that can strategically support one another. This collaborative Agreement between PharmHouse and TerrAscend Canada demonstrates our commitment to provide more than just growth capital to our partners,” continued Linton. “Through the unique access to Canopy Growth, we continue to develop an environment that encourages and supports synergy and mutually advantageous opportunities for value creation across the entire Canopy Rivers platform.”

The PharmHouse joint venture, of which Canopy Rivers owns 49%, operates out of approximately 1.3 million square feet of newly built greenhouse infrastructure under glass in Leamington, Ontario. Canopy Rivers, along with the joint venture partners are actively upgrading and supplementing the facility in preparation for licensing. With this Agreement in place, and pending the receipt of a cultivation licence from Health Canada, PharmHouse has orders for an aggregate 30% of the flowering space at its facility until December 31, 2020.

Fostering opportunities for collaboration throughout the Canopy Rivers ecosystem is a key element and differentiator in the Company’s value proposition. This Agreement is another great example of the portfolio partners leveraging their respective areas of specialization within the cannabis value chain in a manner that is financially and operationally beneficial for all parties.

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX:WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding PharmHouse’s anticipated throughput and low cost of production; supplementing TerrAscend Canada’s logistics platform; the anticipated synergies and value creation across the Company’s platform; PharmHouse’s development in preparation for providing Health Canada with notice of readiness for a cultivation license; receipt of a cultivation license for PharmHouse; and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; construction, development and associated financing risks; the ability of PharmHouse to obtain a license under applicable legislation in Canada; the ability for TerrAscend to secure distribution and sales channels; changes in general economic, business and political conditions, including changes in the financial markets; potential conflicts of interest; the Canadian regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the joint management information circular of Canopy Rivers Corporation and the Company dated August 8, 2018, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact: 

Canopy Rivers Inc.

Karoline Hunter
Sr. Director, Investor Relations & Communications
E-mail: ir@canopyrivers.com

Monday, October 15th, 2018 Uncategorized Comments Off

$NUGL Enters into Letter of Intent to Acquire National Cannabis Publication Company

LOS ANGELES, Oct. 15, 2018  — via NetworkWire – NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry’s new standard of technology, today reports it has entered into a binding letter of intent (“LOI”) to purchase Nichols Publishing Company , Inc. (“Nichols Publishing”), an Iowa based corporation that publishes industry known magazine publications such as the Professional Marijuana Grower and Garden & Greenhouse.

Robin Nichols founded Nichols Publishing over a decade ago and has since grown his magazine publications to a well-known brand.  Subject to a 30-day exclusive due diligence period and the execution of definitive agreements, the Company will acquire 100 percent of Nichols Publishing in exchange for $1 million in NUGL common stock. Following the acquisition, Nichols will join NUGL and will be responsible for the publication operation under the NUGL name.

“Each magazine has a specific audience that is complementary to the NUGL business model.  Professional Marijuana Grower speaks to established businesses and Garden & Greenhouse speaks to the home enthusiast. The NUGL community is made up of businesses and enthusiasts, so these publications are a perfect fit for us. Their reach will expedite getting the word out about NUGL and what we’re all about,” said Ryan Bartlette, CMO of NUGL.

NUGL and Nichols Publishing entered into a joint-venture marketing agreement 30 days ago.

“The synergies between the magazines and NUGL’s software are aligned perfectly. Our user base utilizes our application to perform a function, and then they leave. Now, we can give our user base additional content and redirect NUGL traffic to the magazine and vice versa. Together, both companies are stronger, and we plan to expand the magazines’ readership in a big way,” said Bob Waters, V.P.  of Sales at NUGL.

Acquiring Nichols Publishing is just the beginning as NUGL strives to create a footprint that will help the cannabis industry grow and thrive. Both NUGL’s Android and Apple applications have recently been updated with increased functionality, and the long-awaited menu, which was just released, is receiving great feedback through its testing platform. NUGL is moving fast and continues to surprise the cannabis industry.

Professional Marijuana Grower is published six times per year and distributed to licensed cannabis growing facilities, processors and dispensaries. Each issue offers an affordable way to reach licensed growing facilities in states that have legalized cannabis cultivation. A digital version of each issue that can be read on cell phones and tablets is posted on the publication’s website, which averages more than 6,500 visitors each month. Total print, digital issue subscriber and website distribution is over 23,000 readers per issue. For more information about Professional Marijuana Grower, visit www.professionalmarijuanagrower.com.

Garden & Greenhouse is mailed directly to subscribers, which helps advertisers because it guarantees their ads are viewed by the potential customer each time. Plus, advertisers get the added benefit of more than 5,000 additional newsstand copies that are distributed to hydroponic and indoor gardening retail stores. A digital version of each issue that can be read on cell phones and tablets is posted on the publication’s website, which averages more than 30,000 visitors each month. Total print, digital issue subscriber and website distribution is over 41,000 readers per issue. For more information about Garden & Greenhouse, visit www.gardenandgreenhouse.net.

The Company anticipates completing its due diligence by the end of October 2018 and hopes to have definitive agreements completed for closing by December 2018.

About NUGL

NUGL is the world’s first cannabis search app built for the people, by the people. Our goal is to build the most user-friendly app experience in the cannabis industry by listening to our users and giving them what they want. NUGL is the only cannabis search app that offers equal and unbiased search results. We don’t sell top-spot listings or fake reviews, so our data stays true. Use NUGL to search for genuine user-rated dispensaries, strains, doctors, lawyers, cannabis service providers, vape shops, hydro stores, brands and more. NUGL’s flexible web app has no geographic limitations and can rapidly connect cannabis companies, related vertical services and users. The NUGL iOS and Android app brings a powerful cannabis search tool within reach of anyone, anytime, anywhere with the ease of a smartphone.

For more information and updates, visit one of the links below.

Website: http://www.nugl.com/
Facebook:  https://www.facebook.com/nuglapp/
Instagram: https://www.instagram.com/nuglapp/
Twitter: https://twitter.com/nuglapp/
LinkedIn: https://www.linkedin.com/company/nuglapp/
Newsletter: https://nugl.us16.list-manage.com/subscribe?u=219fe8bb6995a19827c9f36cb&id=dc46712578

Forward-Looking Statements

Certain statements in this press release may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include projections of matters that affect revenue, operating expenses or net earnings; projections of growth; and assumptions relating to the foregoing. Such forward-looking statements are generally qualified by terms such as: “plans”, “anticipates,” “expects,” “believes” or similar words of like kind. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or qualified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. These factors are discussed in greater detail in the company’s business plan and filings with the OTC Markets Group.

Contact Information:

Website: www.nugl.com
Email: info@nugl.com
Phone: (714) 383-9982

Corporate Communications Contact:

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, October 15th, 2018 Uncategorized Comments Off

$YGYI Expanding HempFX Line through Launch of Two Hemp-Derived Cannabidiol Products

  • November debut of ‘HempFX Hydration – Pure’ and ‘HempFX Hydration – Sleep’ is part of YGYI’s focus on growing its non-THC-based CBD business
  • YGYI is a top omni-direct lifestyle company that in August introduced three new proprietary blends of hemp-derived cannabinoid products which sold out at the corporate convention
  • In its September 2018 investor presentation, YGYI explains the importance of vertical integration in its hemp-based non-THC CBD business using a “field-to-finish” strategy

Youngevity International, Inc. (NASDAQ: YGYI) continues to grow its HempFX line with the scheduled November introduction of two new products: ‘HempFX Hydration – Pure’ and ‘HempFX Hydration – Sleep’. These are tablet-based products that utilize the company’s Y-DR8+ proprietary technology (http://nnw.fm/Ge9W7).

The ‘HempFX – Pure’ product will be available in tablet form and can be added to water and dissolved as it is consumed. It is designed to offer 25mg of organic, full spectrum and hemp-derived cannabidiol per tablet. Its goal is to offer, in conjunction with its own portable water bottle system, great tasting and reduced-chemicals tap water. It uses the Y-DR8 filter’s activated carbon cloth (ACC) and its portability is designed to fit the “on-the-go” lifestyle.

‘HempFX – Sleep’ is also a tablet-based product in the line designed to offer a restful night’s sleep with the health benefits of CBD. It combines melatonin with hemp-derived cannabidiol oil in a proprietary beverage enhancement tablet.

YGYI is an omni-direct lifestyle company that uses a hybrid of the direct selling model. It also uses e-commerce and social selling. According to its corporate presentation, its significant market segments include skin care, anti-aging, weight loss, brain health and coffee. It is now entering the cannabis market with its HempFX line. YGYI is also planning for global expansion, focusing primarily on Latin American and Asian markets, with its international revenues already growing significantly this year.

Earlier, YGYI debuted three hemp-based products in the line, which sold out pre-production quantities at ETST’s corporate convention last August. The three blends of cannabinoid will be available to consumers in October, including Soothe, Relax and Uplift (http://nnw.fm/EUg0D).

YGYI’s September 2018 Investor Presentation described its strategy of vertically integrating the hemp-based non-THC CBD industry. It stressed the importance of its “field-to-finish” focus, which maximizes its long term goals of achieving top quality control standards and attaining revenue opportunities across the vertical (http://nnw.fm/FH5Bb).

For more information, visit the company’s website at www.YGYI.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, October 15th, 2018 Uncategorized Comments Off

$SNNVF Closes $23.0 Million Bought Deal Public Offering, Operational Update

VANCOUVER, Oct. 12, 2018 - Sunniva Inc. (“Sunniva” or the “Company”) (CSE: SNN) (OTCQX: SNNVF) is pleased to announce that it has completed its bought deal public offering (the “Offering”) for aggregate gross proceeds of $23,029,900 (All figures are in Canadian dollars unless otherwise stated). A total of 4,370,000 units (the “Units”) of the Company were sold pursuant to the Offering, including 570,000 Units issued as a result of the full exercise of the Underwriters’ over-allotment option, at a price of $5.27 per Unit. The Offering was conducted by a syndicate of underwriters co-led by Beacon Securities Limited and Canaccord Genuity Corp. and including Haywood Securities Inc.

Each Unit consists of one common share (a “Common Share”) in the capital of the Company and one-half (1/2) of one Common Share purchase warrant (each whole warrant, a “Warrant”) of the Company. Each Warrant entitles the holder thereof to acquire one Common Share at an exercise price of $6.85 per Common Share for a period of 24 months from the closing of the Offering.

The Company intends to use the majority of the net proceeds of the Offering to fund ongoing development at the Sunniva Canada Campus greenhouse facility in Okanagan Falls, British Columbia and the Sunniva California Campus greenhouse facility in Cathedral City, California. It is intended that the remaining net proceeds of the Offering will be used by the Company for working capital and general corporate purposes.

The Units issued under the Offering were offered by way of a short form prospectus dated October 4, 2018 (the “Prospectus”) filed in the provinces of British Columbia, Alberta and Ontario and were offered in the United States to Qualified Institutional Buyers pursuant to exemptions from the registration requirements under rule 144A of the United States Securities Act of 1933, as amended, in a manner that does not require the Units to be registered in the United States. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

Operational Update
Significant progress has been made towards the completion of construction of the Sunniva California Campus, a 489,000 square foot purpose built greenhouse cultivation facility in Cathedral City, California and early stage construction continues at the 759,000 square foot Sunniva Canada Campus facility in Okanagan Falls, British Columbia.

In California, Sunniva is now at the point of advancing its business model, moving quickly up the value chain leveraging our cultivation and extraction assets and launching Sunniva brands across all major product categories including pre-rolls, vaporizers and filled cartridges, flower, concentrates, and beverages, while aggressively pursuing distribution and retail dispensary expansion.

In Canada, Sunniva has retained Canaccord Genuity Corp., who has commenced a formal process to review all strategic alternatives which may include a sale of, an investment in, or a joint venture for some or all of the Company’s Canadian assets with the intention to spin out the Company’s Canadian assets into a separate Canadian entity and apply to list its shares on the Toronto Stock Exchange and the NASDAQ Stock Market.

Milestones and objectives that the Company is targeting over the next 12 months include:

Activity Update Current Status
Commence operations of the Sunniva California Campus First harvest from Phase 1 (50,000 kg plus 10,000 kg in associated trim per year) is anticipated in Q1 2019
Launch Sunniva house of brands for multiple product categories in California Anticipated commencing Q4 2018
Pursue vertical integration through distribution and retail acquisitions in California Flagship onsite dispensary expected Q1 2019Corporate development opportunities ongoing
Commence operations of the Sunniva Canada Campus Grading of the site is complete. Foundation work on Phase 1 has commenced and is approximately 90% complete
Phase 1 (50,000 kg plus 10,000 kg in associated trim per year) is anticipated to commence operations with the first harvest in Q3 2019

 

Please see the updated Corporate Presentation and Fact Sheet at www.Sunniva.com/Investors/

About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California. Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through strategically positioned cultivation and extraction facilities, Sunniva intends to launch a suite of branded products in various product categories including flower, pre-rolls, beverages, vape cartridges, extracts while beginning to pursue upstream opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

For more information please visit: www.sunniva.com.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements relating the use of proceeds of the Offering, future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding the terms, conditions, timing and completion of strategic initiatives; statements regarding the use of proceeds from the Offering; stock exchange listings; unlocking of value; Sunniva’s plans regarding strategic alternatives involving some or all of Sunniva’s Canadian assets; Sunniva’s projected milestones and objectives over the next 12 months, Sunniva’s plan to cultivate, produce, manufacture and distribute a broad range of solutions focused on patients’ and customers’ needs and Sunniva’s plans, timing and estimates for its facilities, are “forward-looking statements.” Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Prospectus and Sunniva’s continuous disclosure documents available on www.sedar.com. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Sunniva has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Sunniva assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

SOURCE Sunniva Inc.

Company Contact: Dr. Anthony Holler, Chairman and Chief Executive Officer; Investor Contact: Phil Carlson / Erika Kay, KCSA Strategic Communications, Phone: (212) 896-1233, Email: pcarlson@kcsa.com / ekay@kcsa.com; Media Contact: Katelyn Tumino, KCSA Strategic Communications, Phone: (212) 896-1252, Email: ktumino@kcsa.comCopyright CNW Group 2018

Friday, October 12th, 2018 Uncategorized Comments Off

$YGYI CBD is Key to Myriad of Health Products Across the Globe

NEW YORK, Oct. 12, 2018 — via CannabisNewsWire – CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Youngevity International, Inc. (NASDAQ: YGYI), a client of CNW offering a hybrid of the direct selling business model that combines e-commerce and the power of social selling.

To view the full publication, titled “CBD Exploding into Mainstream Wellness Products,” visit: http://cnw.fm/2iUTp

The new HempFX products expand YGYI’s CBD line and join a vast stable of more than one thousand products and services the company already offers. The new tablet-based CBD products are designed to work in conjunction with Youngevity’s Y-DR8+ proprietary water bottle system. The company’s exclusive Y-DR8 filter utilizes activated carbon cloth designed to reduce chemicals and deliver CBD in great tasting water. The portable Y-DR8 filter holds cannabidiol tablets above the water line, and YGYI’s CBD formulations are infused into the water as it flows over the tablets.

One thing that makes Youngevity so unique is our broad product offering,” President and CFO Dave Briskie stated during the company’s 2018 convention. “It allows us to reach many markets and gives our customers a wide range of high-quality lifestyle products. We will continue to do our best to align our products to the needs of our market.”

About Youngevity International, Inc.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers proven products from the six top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The company was formed during the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com

About CannabisNewsWire (CNW)

CannabisNewsWire (“CNW”) is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information please visit https://wwwCannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://CNW.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

CNW Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Friday, October 12th, 2018 Uncategorized Comments Off

$YGYI CBD Exploding into Mainstream Wellness Products

CannabisNewsWire Editorial Coverage: Bolstered by millennia of anecdotal evidence and ever-mounting scientific validation, cannabidiol (CBD) is rapidly being integrated into myriad mainstream consumer wellness products around the globe.

  • Global cannabis market expected to quadruple to over $63 billion by 2024
  • CBD oil market to grow at CAGR of 39.19 percent through 2021
  • CBD products exploding into a wide variety of product lines
  • Diversified, sales-driven companies expected to outpace standard growth curve

Humans have used hemp, a variety of Cannabis sativa and a primary source of CBD, for more than 10,000 years in food, textiles and medicine. The world is again recognizing the therapeutic benefits of hemp extracts, and consumers are embracing cannabis-based products at a breakneck pace. Consumer demand has triggered an explosion of product innovations that range from oils and edibles to pet products and infused beverages. Intent on staying at the vanguard of the upsurge in CBD-based wellness products, sales and marketing powerhouse Youngevity International, Inc. (NASDAQ: YGYI) (YGYI Profile) recently expanded its HempFX™ line with the launch of two new hemp-derived cannabidiol products. Others are entering the sector as well. Beer and spirits conglomerate Constellation Brands, Inc. (NYSE: STZ) just made the largest investment to date in the cannabis industry. AbbVie Inc. (NYSE: ABBV) was one of the first companies to enter the pharmaceutical cannabis space with Marinol, which is almost chemically identical to THC, the main component in marijuana. Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) offers DehydraTECH, a drug delivery platform that could be a game changer for several industries, including the recreational and medical cannabis markets. And Neptune Wellness Solutions, Inc. (NASDAQ: NEPT) recently received a Confirmation of Readiness letter from Health Canada, a key milestone in its quest to become a licensed producer of cannabis oil in Canada.

The CBD Boom

Cannabidiol is understandably generating worldwide interest from both the scientific and investment communities.  It’s hard to ignore a market sector projected to nearly quadruple from about $16 billion last year to more than $63 billion worldwide by 2024. In just the United States alone, the marijuana industry could create an economic tsunami estimated to surge past $75 billion annually by 2022.

Explosive demand projections are attributed to increased public awareness about wide-ranging potential health benefits, natural pain mitigation and anti-inflammatory properties, advancements in cultivation and processing, plus the convenience and reach of online and direct retailing — all of which contribute to a global CBD oil market expected to grow at an eye-popping CAGR of 39.19 percent through 2021. The upward trend is indisputable, and corporations are jockeying for position, racing to produce a variety of CBD products, staking out distribution channels and opening a realm of possibilities in previously unimagined markets. All the projections and activity send clear signals of what’s to come.

The Mission Matters

With deep roots in health and nutrition spanning over 20 years, omni-direct lifestyle company Youngevity International, Inc. (NASDAQ: YGYI) is still dedicated to the core mission of its founder: learning how to live younger, longer. Expanding on the pioneering biomedical research of Dr. Joel D. Wallach, Youngevity is aggressively and ethically growing its business through a unique admixture of direct selling, traditional marketing, mergers and acquisitions, and stellar organic growth. The direct sales model and international roll-out strategies of Youngevity provide synergistic leverage to capitalize on the immense potential in high-growth emerging markets, exactly what’s occurring in the CBD arena.

Youngevity’s recent announcement about the launch of two new hemp-derived cannabidiol products in its HempFX line intermeshes with the company’s explosive sales growth and its mission to provide nutritional and lifestyle solutions to achieve optimum health and wellness goals. “Plant-based nutrition is fundamental to our product development philosophy,” stated Youngevity CEO Steve Wallach.

The new HempFX products expand YGYI’s CBD line and join a vast stable of more than one thousand products and services the company already offers. The new tablet-based CBD products are designed to work in conjunction with Youngevity’s Y-DR8+ proprietary water bottle system. The company’s exclusive Y-DR8 filter utilizes activated carbon cloth designed to reduce chemicals and deliver CBD in great tasting water. The portable Y-DR8 filter holds cannabidiol tablets above the water line, and YGYI’s CBD formulations are infused into the water as it flows over the tablets.

“This bottle system is intended to provide people with a revolutionary point-of-use water system for great tasting water and enables consumers to customize tap water based upon their health and wellness needs. It is a beverage technology that we expect will have broad consumer appeal and we are extremely excited to combine this technology with the benefits of hemp-based CBD,” stated Vice President of Innovation and Emerging Markets Rick Anson.

Using patent-pending extraction and bioavailability processes, YGYI’s HempFX products contain only U.S. organically grown non-GMO hemp. The full-spectrum phytocannabinoids are third-party tested to ensure only the highest quality allergen-, gluten- and THC-free hemp oils are produced and sold to the public in compliance with good manufacturing practice (GMP) standards.

HempFX Hydration™ – Sleep is formulated to improve sleep patterns and deliver the health benefits of CBD. YGYI’s high-quality cannabidiol formulation contains melatonin and is administered using the company’s proprietary beverage enhancement tablet. HempFX Hydration – Pure contains 25 mg of organic, full-spectrum, hemp-derived cannabidiol oil per tablet and quickly dissolves in water as it is consumed.

“Plant-based nutrition is fundamental to our product development philosophy,” Wallach stated. “That’s why we’re especially excited to enter this rapidly growing market with two new products.”

HempFX Hydration – Sleep and HempFX Hydration – Pure are expected to be available next month, and sales may well outperform YGYI’s three other hemp-based products, which sold out of preproduction quantities during the company’s August sales convention.

Sales and Marketing Powerhouse

Recognized as one of the Top 100 Global Direct Selling Companies, Youngevity is a sales powerhouse that more than doubled revenues from $75 million in 2012 to $166 million in 2017. The company shows no signs of slowing down, posting an 8.7 percent revenue increase in Q2 YTD 2018 over Q2 YTD 2017 and a 9.6 percent increase in gross profits over the same period.

The NASDAQ-listed company, added to the Russell Index in June, operates in large, scalable global market segments driving significant revenue growth in skin care, anti-aging, weight loss, brain health and coffee. The expansion into CBD products appears likely to boost revenues even further, potentially placing the company at the forefront of the CBD boom. Making quality products is only one aspect of carving out space in this new sector; sell-through is the more important criteria to measure success during the upswing.

Youngevity’s unique marketing hybrid buttressing the direct-selling business model with powerful e-commerce and social selling initiatives has created a global panoply of products and services under one corporate umbrella that supports healthy, empowered lifestyles. Youngevity now offers more than one thousand high-quality nutritional and lifestyle products and services through a wide range of channels in fast-growing retail categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and Scrapbooking
  • Services for Home and Business

One thing that makes Youngevity so unique is our broad product offering,” President and CFO Dave Briskie stated during the company’s 2018 convention. “It allows us to reach many markets and gives our customers a wide range of high-quality lifestyle products. We will continue to do our best to align our products to the needs of our market.”

The Epiphany

There’s little doubt about the trajectory of the global CBD market. Some have likened the impending surge of industry players to the dot.com era — some will become Amazon.com while others will disappear faster than Pets.com. Investors looking to capitalize on the immense opportunity ahead are likely best served by strategic positions in diversified companies driven by sales and galvanized by a mission to excel.

Others in the Arena

Constellation Brands, Inc. (NYSE: STZ) just made the largest investment to date in the cannabis space. The company is already a leading international producer and marketer of beer, wine and spirits. With its $4 billion investment in Canopy Growth Corp. (NYSE: CGC), Constellation looks to accelerate its market position and expand its portfolio in emerging cannabis markets around the globe.

Primarily a pharmaceutical company, AbbVie Inc. (NYSE: ABBV) offers a synthetic cannabis-based drug on the market. Marinol is an FDA-approved, prescription drug used to alleviate nausea or vomiting for chemotherapy patients; it may also help AIDS patients who have lost their desire to eat.

Lexaria Bioscience Corp.’s (CSE: LXX) (OTC: LXRP) DehydraTECH drug delivery platform features a patented, cost-effective delivery mechanism that improves the taste and smell — as well as the bio-absorption — of ingestible substances. Cannabinoid-infused edibles and concentrates represent the fastest-growing segments of the cannabis industry, and DehydraTECH may position Lexaria as a prime partner for offerings in these spaces.

Working to develop unique extracts and formulations in the legal cannabis wellness field, Neptune Wellness Solutions, Inc. (NASDAQ: NEPT) is well on its way to obtaining official approval to move forward. The Confirmation of Readiness letter “brings us to the threshold of becoming a Licensed Producer of cannabis oil in Canada, and is a very exciting moment,” said Neptune president and CEO Jim Hamilton. “Our entry into the legal cannabis industry leverages our established expertise in the development of innovative Omega3 oil products, navigating global regulatory frameworks, worldwide commercialization of wellness solutions, and production of high-quality extracts.”

For more information on Youngevity, visit Youngevity International, Inc. (NASDAQ: YGYI)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Thursday, October 11th, 2018 Uncategorized Comments Off

$TGODF advances international expansion through joint venture entering Latin America

TORONTO, Oct. 11, 2018 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce it has entered into a strategic joint venture with LLACA Grupo Empresarial to create a 50/50 owned company to enter the medicinal cannabis market in Mexico. With this partnership, TGOD continues the expansion of its international portfolio, with sales and operations in multiple countries and continents around the world.

LLACA has developed proprietary distribution capabilities and has access to premier distributors with commercialized pharmaceutical and over-the-counter products providing access to 4,500 pharmacies and 3,100 supermarkets throughout Mexico.

LLACA will facilitate the importation, registration and strategic distribution of TGOD-branded organic cannabis and hemp-derived medical products into the Mexican market. LLACA has many years of distribution experience in Mexico, operating a significant warehouse network that provides 100% coverage within the country. This distribution network meets all technical requirements of the Mexican Ministries of Health and Finance to sell narcotics and nutraceuticals.

“This partnership combined with the recently proposed regulations for the Mexican medicinal cannabis market provides TGOD with a significant first mover advantage, at scale,” said Brian Athaide, CEO of TGOD. “This is a pivotal step in our strategy to export TGOD branded products produced in Jamaica, Poland, and soon to be Canada and Denmark for the global markets. The distribution network includes over 7,600 potential retailers, significantly expanding our international footprint.”

Beyond distribution, the joint venture will give TGOD full access to LLACA’s strategic services, including distribution, warehousing, product registrations, regulatory representations and authorized clinical trials. These services are used by several international and national pharmaceutical companies.

“The Mexican population is approximately 125 million people, or roughly 3.5 times the size of Canada’s population. We are thrilled to establish a presence in Latin America through Mexico with this strategic partnership,” said Csaba Reider, TGOD’s President. “This partnership with LLACA aligns us with an experienced commercial leader in a key strategic market. This is an exciting step in TGOD becoming the global leader in premium, organic cannabis.”

“We are pleased to be partnering with TGOD,” said Alejandro Perea, Medical Cannabis Commercialization Director of LLACA. “We respect TGOD’s organic principles, which will serve well in the medical market in Mexico. We like their forward-thinking management and are excited about the brand. We expect that the Mexican market is ready for the organic cannabis story.”

On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.

ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.

The Green Organic Dutchman Holdings Ltd. is a premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe and Latin America and the soon to be legal Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg and is building 1,382,000 sq. ft. of cultivation facilities across Ontario, Quebec and Jamaica.

The Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX:ACB) whereby Aurora has invested approximately C$78.1 million for 20% offtake from TGOD’s local production. In addition, TGOD has raised approximately C$350 million and has over 20,000 shareholders.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about the future legalization of recreational cannabis and cannabis-infused products in Canada, statements about future research, development and innovation by the Company, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

Thursday, October 11th, 2018 Uncategorized Comments Off

$SNNVF 420 with CNW – Opioid Alternative Launched in California by Cannabis Company

C3 International recently launched a ground-breaking painkiller derived from cannabis as an alternative to the conventional prescription opioids that have been linked to so many issues, such as the possibility of addiction, constipation, incoherence, loss of appetite and other side effects.

The pill made by C3 International is unique because it is a standardized product that can be trusted to deliver the same results at a given dosage for those who use it.

The company says that its product doesn’t have any psychoactive ingredients since only CBD was extracted and added to a formulation of other ingredients calculated to provide different doses of marijuana based on the needs of a patient.

The tablet provides an easy way for doctors to prescribe and ensure that a patient is consuming the required quantity of the therapeutic product within the stipulated intervals.

This is different from what has been happening with the existing edible or smoking marijuana products whose medicinal content often varied from one batch purchased to the next. It is also common for the ingredients to vary from one plant to another. This makes it hard to be certain that the patient is receiving the exact quantity of curative ingredients to produce the desired results without triggering any unwanted effects.

The ingredients used to make the new pill are extracted from cloned plants which yield a uniform amount and quality of the desired ingredients. One can therefore be sure that each pill will contain exactly the same amount of ingredients as any other pill made by the same manufacturer.

Unfortunately, this product is only available within the state of California, so patients elsewhere may have to wait. Federal laws prohibit marijuana or any products derived from it to cross state lines, so the new pill cannot be provided outside California.

Those who are within California may also be pleased to learn that several insurance providers will cover the cost of getting these novel pills. One simply has to contact their insurer and confirm that the company can be billed for the cannabis pills.

The pill launched by C3 International is likely to be one of many new products which will hit the market in the states where marijuana has been decriminalized in some form. If one could only take a sneak peek into Sugarmade, Inc. (OTCQB: SGMD) and Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to learn what they intend to introduce on the rapidly evolving marijuana market!

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Thursday, October 11th, 2018 Uncategorized Comments Off

$PFSF Proprietary Hyperledger Platform, Agri-Blockchain, IoT

  • Blockchain-based B2B/B2C e-commerce platform currently under development
  • Agri-Blockchain solutions will initially focus on the agricultural supply chain between China and Brazil
  • Internet of Things integration will allow enhanced product tracking, as well as safety and management of complex supply chains

An emerging development technology corporation and master licensor of Hyperledger blockchain-based systems, Pacific Software, Inc. (OTC: PFSF) is currently working on a proprietary e-commerce trade platform targeting both the business-to-business and business-to-consumer sectors. The platform, set to launch in November of this year, will initially focus on the agricultural supply chain between China and Brazil, which primarily facilitates beef trade between the two countries, and integrating with international distribution channels (http://nnw.fm/zV6q5).

By integrating the company’s Agri-Blockchain technology, the platform will offer increased transparency and trust regarding origin, quality and safety of products in the supply chain. This will also help speed up removal of contaminated food, making it easier to trace the source of contamination, thus reducing costs exponentially. Using IBM’s Hyperledger Blockchain “Backend as a Service” infrastructure, Pacific Software’s platform will be able to store, record and track digital product information from farm to fare, including batch identification numbers, expiration dates, factory and processing information, shipping details and more.

To further enhance transparency of supply chains, Pacific Software is working on integrating Internet of Things capabilities into the platform – more specifically the ability to incorporate data from Internet-connected devices such as RFID or barcode readers. By linking to the Internet of Things, the platform will be able to gather valuable product data and make complex supply chains more manageable and overall safer.

The blockchain-platform could be used successfully to track supply chains in any field of agriculture, as a growing number of agricultural sectors are already beginning to consider the benefits of blockchain applications for enhanced transparency and increased customer trust. The U.S. Dairy Farmers of America, a farmer-owned cooperative with more than 14,500 members, announced recently (http://nnw.fm/9kSUW) that it would be using a blockchain platform to track milk products so as to give “consumers real-time data, which can really help increase trust and confidence about food production from start to finish.”

Pacific Software’s multilingual platform is developed by Cobalt 47 Technologies Ltd., a spin-off of leading Chinese Microsoft distributor KBQuest Group, Inc., under an agreement signed in August of this year. While the primary focus remains trade and supply chains between Brazil and China, the technology could have a much wider application in industries where effective product tracking methods and supply chain management are required, such as the cannabis market – to improve seed-to-sale supply chain traceability and management – and opioid/controlled substance management – to create a verifiable and trusted ledger between manufacturers and consumers.

With the drug supply chain in particular, the Pacific Software platform could prove to be a valuable tool in combating the current opioid epidemic, which is estimated to have cost the U.S. more than a trillion dollars since 2001 (http://nnw.fm/9N0nz). The Hyperledger blockchain system would allow for better bookkeeping, which would help track drugs from production to final use, helping identify pill mills that overprescribe painkillers or cases of double doctoring where patients take out prescription from different doctors.

Pacific Software is already considering the potential impact of blockchain technology in this field by assessing how its platform could help struggling African countries deal with counterfeit drugs and medications. The issue was discussed during a recent meeting between company officials and representatives of the African Chamber of Commerce focused on building a partnership for trade.

For more information, visit the company’s website at www.PacificSoftwareInc.com

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, October 11th, 2018 Uncategorized Comments Off

$YGYI Roots in the CBD Market, CannabisNewsWire Announces Publication

  • Youngevity is a top omni-direct lifestyle business
  • The company is leveraging growth opportunities related to cannabidiol oil
  • Company added two new hemp-derived cannabidiol products, expanding HempFX line to five offerings

Youngevity International, Inc. (NASDAQ: YGYI) is among the ‘Top 100 Global Direct Selling Companies’. Along with unique services, Youngevity offers products from the top selling retail categories. These categories include health/nutrition, home/family, food/beverage, spa/beauty, fashion, essential oils and photo. The company distributes its products and services via a worldwide network of preferred customers and distributors. A foremost omni-direct lifestyle company, Youngevity International has its corporate headquarters in Chula Vista, California.

Youngevity offers a hybrid of the direct selling business model. This model encompasses person-to-person selling relationships, which consist of a “network of networks.” This model additionally offers e-commerce and the power of social selling. The company offers a host of consumer products and services. This includes its diverse gourmet boutique coffee blends from wholly-owned subsidiary CLR Roasters. CLR Roasters’ products are produced through a vertically integrated “farm-to-cup” pipeline.

Furthermore, Youngevity is in the process of entering the cannabis market. The company’s plant-based nutrition experts are guiding its team toward the development of a complete line of proprietary hemp-derived cannabidiol oil products (http://cnw.fm/j1IK8).

Cannabidiol supplements are set to burst out ahead of biopharma as the Farm Bill legalizes hemp. This is according to CannabisNewsAudio, which recently announced an Audio Press Release (APR) regarding this milestone featuring Youngevity International, Inc. Furthermore, the complete legalization of recreational marijuana is set for Canada this month, so opportunities exist in this marketplace (http://cnw.fm/9XowW). In addition, cannabis is swiftly moving toward decriminalization throughout the worldwide marketplace.

Youngevity International is positioned to take advantage of growth opportunities to serve the new demands of consumers. The company just announced the expansion of its HempFX line with the launch of two new hemp-derived cannabidiol products: HempFX Hydration – Sleep and HempFX Hydration – Pure. In a news release, Steve Wallach, chief executive officer of Youngevity International, said, “Plant-based nutrition is fundamental to our product development philosophy. That’s why we’re especially excited to enter this rapidly growing market with two new products.”

The company is employing its “field-to-finish” strategy regarding its hemp-based cannabidiol business. This strategy is much akin to its coffee business strategy and involves a complete approach to cultivation, production and distribution. Strict quality control is the primary aim.

The company’s new proprietary HempFX line of hemp-derived cannabidiol oil products perfectly complements its product development philosophy. With this philosophy and its business strategy, Youngevity International foresees growing revenue opportunities across the vertical as it innovates with pioneering products and services.

For more information, visit the company’s website at www.YGYI.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Wednesday, October 10th, 2018 Uncategorized Comments Off

$TGODF Issues Corporate Update

TORONTO, Oct. 10, 2018 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD, US:TGODF) is pleased to provide the following update on its operations.

$75 Million Bought Deal Financing

TGOD is committed to becoming the largest organic cannabis brand in the world, and the Company is on an excellent path with the additional $75 million bought deal financing announced last week. This additional capital will be used to advance the Company’s rapid and strategic international expansion plan, with the next phases of growth to focus on Europe and Latin America. With potential consumer populations of nearly 750,000,000 and 650,000,000 respectively, these markets represent a key development opportunity in the Company’s global growth plan. The Company will utilize the funds from the financing to establish strategic product manufacturing, which adheres to the Company’s proprietary organic growing principles, and robust sales and distribution capabilities across Europe and Latin America. Within these markets and beyond, TGOD will continue to invest in global cultivation opportunities and technology partnerships to deliver unique and innovative forms of its premium organic product to consumers.

International Expansion

TGOD has made substantial progress towards its goal of having operations in 12 countries on 3 continents by the end of 2018 with its recently announced investments in Jamaica and Poland, and the planned expansion in Denmark.

In Jamaica, TGOD’s partner Epican is on track to open 5 dispensaries by Q1 of 2019, including the flagship store in Kingston that opened in July. Cultivation on the Company’s newly leased land is on schedule for completion in the fourth quarter of 2018. This new site brings TGOD’s productive capacity in Jamaica to 14,000 kgs, a large portion of which will be dedicated to TGOD branded products for export to global markets.

Last week, TGOD closed the acquisition of HemPoland. Europe is home to three-quarters of a billion potential consumers, and HemPoland is a leading manufacturer and marketer of premium CBD oils within this market. This acquisition provides TGOD with access to HemPoland’s significant distribution network, state-of-the-art hemp oil extraction technology and the premium top selling Cannabigold brand. The transaction also provides immediate revenue for TGOD. The Company has also made excellent progress with its joint venture partner in Denmark, in developing R&D and cultivation capabilities. An application has been filed for a cannabis cultivation license from the Danish authorities, and approval is expected during the last quarter of 2018.

TGOD is focused on building the leading organic cannabis brand in the world, and will be bringing leading  technologies  to its production in Jamaica, Poland and Denmark. This will ensure TGOD’s brand has the best efficacy and product delivery for medical patients and adult use consumers across all product forms.

Facility Construction

In Canada, TGOD continues to make progress on construction in both Hamilton and Valleyfield. The facilities consist of high efficiency sites conforming to GMP standards with LEED certification. Timelines remain on schedule with cultivation beginning Q1 2019 in Hamilton, Ontario and in Q2 in Valleyfield, Quebec.

Please click here for the latest videos.

Brand Development

The Company has been working with consumers around the globe to gain valuable insights to shape the development of the TGOD brand. The response to organically-certified cannabis has been very strong across both the recreational and medicinal markets and the response to the TGOD brand name has been strong across multiple countries and languages.

Please visit the Company’s previously issued press release for a look and feel of TGOD’s premium organic cannabis brand by clicking here.

TGOD is preparing to launch a “Founders Club” to select medical patients in January 2019. The Company will then expand its product offerings to more patients during the first half of 2019, and further to recreational markets in the second half of the year. TGOD expects to have full national distribution across all provincial and territorial adult use market during 2019.

Strategic Talent Acquisition

TGOD continues to make significant progress on the buildout of its skilled leadership team with unprecedented experience in CPG and branded product, pharma and retail. Management is focused on quality of execution and being a leader in leveraging the experience of its team to shape the future path of the global cannabis industry. With the newest additions to our senior team, the Company now has over 200 years of CPG experience

The Company has also added Tim Seymour to its advisory board to assist with US strategies, including planning for a NYSE listing.

On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.

ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.

The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg and is building 1,382,000 sq. ft. of cultivation facilities in Ontario, Quebec and Jamaica.

The Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX:ACB) whereby Aurora has invested approximately C$78.1 million for 20% offtake from TGOD’s local production. In addition, TGOD has raised approximately C$350 million and has over 20,000 shareholders.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about the future legalization of recreational cannabis and cannabis-infused products in Canada, statements about future research, development and innovation by the Company, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

Wednesday, October 10th, 2018 Uncategorized Comments Off